Medpace Holdings, Inc. revenue breakdown overview

Medpace Holdings, Inc. revenue for the last year amounted to 1.89 B USD, the most of which — 587.10 M USD — came from its highest performing source at the moment, Oncology, the year earlier bringing 467.80 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Medpace Holdings, Inc. 1.85 B USD, and the year before that — 1.43 B USD.